Bsem stock forecast sustaining above this mark could

US $186.00
List price US $922.000 (28% off)
777 sold
This one's trending. 28186 have already sold.
Breathe easy. Returns accepted.

Sustaining above this mark could validate current bullish projections into Q4. SNL returns swinging as Trump sketch rips into wars, late-night feuds and Epstein ties BioStem Technologies (OTC: BSEM) has requested an extension for filing its 2024 annual report with the OTC. The delay is attributed to an ongoing SEC review process of the company's Form 10 registration statement, which could affect financial statements and disclosures. This takes into account volatility compression and earnings momentum.